全球乳癌诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计乳癌诊断市场将从 2025 年的 43.2 亿美元成长到 2034 年的 86.2 亿美元，2026 年至 2034 年的复合年增长率为 7.98%。

由于乳癌发生率不断上升以及早期检测的重要性日益凸显，全球乳癌诊断市场正快速成长。乳房X光检查、超音波、磁振造影和切片检查等诊断技术被广泛用于识别和评估乳癌。人们对定期体检和预防医学意识的提高，促使更多人接受早期诊断检测。

影像学和分子诊断技术的进步正在提高乳癌检测的准确性和效率。数位乳房X光摄影、3D乳房摄影和生物标记检测正在帮助医疗专业人员更早发现癌症，从而製定更有效的治疗方案。医疗机构也正在投资先进的诊断设备，以加强其癌症筛检计画。

随着各国政府和医疗机构大力进行乳癌防治宣传活动和筛检工作，市场预计将持续扩张。癌症诊断和个人化医疗研究的进步将进一步提升检测能力。由于早期诊断已成为癌症治疗的关键环节，对先进乳癌诊断技术的需求也将持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球乳癌诊断市场：按类型划分

• 市场分析、洞察与预测
• 诊断影像
• 切片检查
• 基因组检测
• 验血
• 其他的

第五章 全球乳癌诊断市场：依产品划分

• 市场分析、洞察与预测
• 基于平台的产品
• 诊断影像

第六章 全球乳癌诊断市场：依应用划分

• 市场分析、洞察与预测
• 筛检
• 诊断与预测
• 预后
• 研究

第七章：全球乳癌诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 医学检查室和诊断中心
• 其他的

第八章 全球乳癌诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Hologic Inc
  • Genomic Health（Exact Sciences Corporation）
  • BD
  • Danaher
  • Koninklijke Philips NV
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Argon Medical Devices Inc
  • Myriad Genetics
  • F. Hoffmann-La Roche Ltd

The Breast Cancer Diagnostics Market size is expected to reach USD 8.62 Billion in 2034 from USD 4.32 Billion (2025) growing at a CAGR of 7.98% during 2026-2034.

The global breast cancer diagnostics market is growing rapidly due to the increasing incidence of breast cancer and the rising importance of early detection. Diagnostic technologies such as mammography, ultrasound, MRI, and biopsy testing are widely used to identify and evaluate breast tumors. Growing awareness about routine screening and preventive healthcare is encouraging more individuals to undergo early diagnostic testing.

Technological advancements in imaging and molecular diagnostics are improving the accuracy and efficiency of breast cancer detection. Digital mammography, 3D breast imaging, and biomarker testing are helping healthcare professionals identify cancer at earlier stages, enabling more effective treatment planning. Healthcare institutions are also investing in advanced diagnostic equipment to enhance cancer screening programs.

The market is expected to continue expanding as governments and healthcare organizations promote breast cancer awareness campaigns and screening initiatives. Increasing research in cancer diagnostics and personalized medicine will further enhance detection capabilities. As early diagnosis becomes a critical component of cancer care, demand for advanced breast cancer diagnostic technologies will continue to grow.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Imaging
• Biopsy
• Genomic Tests
• Blood Tests
• Others

By Product

• Platform-Based Products
• Imaging

By Application

• Screening
• Diagnostic & Predictive
• Prognostic
• Research

By End Use

• Hospitals & Clinics
• Medical Labs & Diagnostics Centers
• Others

COMPANIES PROFILED

• Hologic Inc, Genomic Health Exact Sciences Corporation, BD, Danaher, Koninklijke Philips NV, QIAGEN, Thermo Fisher Scientific Inc, Argon Medical Devices Inc, Myriad Genetics, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Genomic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Blood Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Platform-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic & Predictive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Prognostic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medical Labs & Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Product
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Product
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Product
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Product
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Product
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BREAST CANCER DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Hologic Inc
  • 10.2.2 Genomic Health (Exact Sciences Corporation)
  • 10.2.3 BD
  • 10.2.4 Danaher
  • 10.2.5 Koninklijke Philips N.V
  • 10.2.6 QIAGEN
  • 10.2.7 Thermo Fisher Scientific Inc
  • 10.2.8 Argon Medical Devices Inc
  • 10.2.9 Myriad Genetics
  • 10.2.10 F. Hoffmann-La Roche Ltd